High-Throughput CRISPR-Cas13 SARS-CoV-2 Test.
BACKGROUND: The ability to control the spread of COVID-19 continues to be hampered by a lack of rapid, scalable, and easily deployable diagnostic solutions. METHODS: We developed a diagnostic method based on CRISPR (clustered regularly interspaced short palindromic repeats) that can deliver sensitiv...
| Publicado en: | Clinical Chemistry Vol. 68; no. 1; pp. 172 - 181 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
Jan2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |